BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3938829)

  • 1. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M; Kovac T; Bujas M; Pusac R
    Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inappropriate gonadotropin secretion in the polycystic ovary syndrome].
    Pilotti L; Data PG; Di Tano G
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1885-90. PubMed ID: 6440582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma follicle-stimulating and luteinizing hormones and the macrosopic characteristics of the ovaries in patients with stein-leventhal syndrome. Response to LH-RH in Stein-Leventhal syndrome.
    Valkov IM; Dokumov I
    Endocrinologie; 1977; 15(1):55-8. PubMed ID: 322249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism].
    Maleeva A; Milkov V; Visheva N; Kekhaĭova M
    Vutr Boles; 1990; 29(3):93-9. PubMed ID: 2178292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
    Singh KB; Mahajan DK; Wortsman J
    J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome.
    Venturini PL; Alibrandi MP; Costantini S; Gaggero G; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):295-7. PubMed ID: 6803505
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of insulin resistance in the idiopathic hirsutism.
    Sarac F; Saygili F; Ozgen G; Tuzun M; Yilmaz C; Kabalak T
    Gynecol Obstet Invest; 2007; 63(3):126-31. PubMed ID: 17057397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the source(s) of hyperandrogenism in women with idiopathic hirsutism.
    Leite V; Devesa J; Valdés L; Sobrinho LG
    Horm Metab Res; 1990 Sep; 22(9):499-503. PubMed ID: 2147915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].
    Xu XH; Tan YC; Shi YH; Wang B; Ju XQ; Zheng QM; Hao CF; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2604-6. PubMed ID: 20137675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum LH levels in the differential diagnosis of hirsute anovulatory women.
    Oppermann K; Cho MM; Spritzer PM
    Braz J Med Biol Res; 1993 Aug; 26(8):799-803. PubMed ID: 8298514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin releasing hormone test: diagnostic significance and limits in menstrual pathology.
    Venturoli S; Nardi M; De Aloysio D; Magrini O; Flamigni C
    Acta Eur Fertil; 1976 Mar; 7(1):1-38. PubMed ID: 785926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relations between polycystic ovary and idiopathic hirsutism].
    Montesanti F; Rama GP; Francia G; Adami S; Lo Cascio V
    G Clin Med; 1988 Mar; 69(3):183-5. PubMed ID: 2971587
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.
    Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
    Int J Fertil; 1992; 37(2):111-4. PubMed ID: 1349592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal aspects in the diagnosis of hirsutism].
    Maleev A; Milkov V
    Akush Ginekol (Sofiia); 1989; 28(1):60-6. PubMed ID: 2742087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.